Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2015-02-28
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The SAVI SCOUT is intended to assist surgeons in the location and retrieval of a non-palpable abnormality as localized by radiographic or ultrasound methods. In this study, the ability of the SAVI SCOUT to guide surgeons to find a lesion will be evaluated instead of the standard technique of wire localization.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lesion Detection of Automated Breast Ultrasound Compared With Handheld Physician-performed Breast Ultrasound
NCT02310776
Early Feasibility Study of the "Easy Light" Fluorecence Imaging System
NCT05004623
Safety & Accuracy of the ActiSight Needle Guidance System in Percutaneous Chest Aspiration and Biopsy
NCT00814450
Classification of Breast Masses Based on Visco-elastic Properties Using SAVE Method
NCT04841252
Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe
NCT05399082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Final data analysis will be completed within 1 month after the last patient is treated.
Final assessment of the surgical results will be completed by the surgeon during a routine follow-up visit within 1 month following the surgical excision or lumpectomy procedure.
Main Objective: to show that the SAVI SCOUT technique can be used to safely and effectively locate a non-palpable breast lesion during a localized excisional biopsy or lumpectomy procedure.
Up to 10 sites and 150 patients will be enrolled.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SAVI SCOUT device
SAVI SCOUT device used to localize breast lesion which will then be removed surgically. The SAVI SCOUT is the intervention for localization of breast lesions.
Localization of breast lesion
localization of breast lesion for removal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Localization of breast lesion
localization of breast lesion for removal
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Lesion depth ≤ 3 cm from the skin surface in the supine position
* Patient is scheduled for excision or BCT at a participating institution
* Patient is between the ages of 18 and 90 years
* Patient is female
* Patient is willing and able to comply with all study procedures and be available to follow-up for the duration of the study
Exclusion Criteria
* Patient had a previous ipsilateral breast cancer
* Patient has multicentric breast cancer
* Patient has Stage IV breast cancer
* Patient has been treated with neoadjuvant chemotherapy
* Patient is pregnant or lactating
\-
18 Years
90 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of South Florida
OTHER
Cianna Medical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Charles Cox, MD
Role: PRINCIPAL_INVESTIGATOR
University of South Florida
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00019820
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.